BCCM
RMTI icon

Blue Clay Capital Management’s Rockwell Medical RMTI Stock Holding History

Blue Clay Capital Management’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$253K Buy
+344
New +$279K 0.29% 68

Other funds holding RMTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BA
BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return

Blue Clay Capital Management's RMTI Position: Q3 2016 in Review

Blue Clay Capital Management opened a new position in Rockwell Medical (RMTI) in Q3 2016: 344 shares worth $253K. The stake represents 0.29% of the portfolio and ranks #68 among its holdings.

88 funds tracked by Wall St. Rank hold RMTI as of Q3 2016.

  • Blue Clay Capital Management held 344 shares of Rockwell Medical worth $253K as of Q3 2016.
  • Rockwell Medical was a new Blue Clay Capital Management position in Q3 2016.
  • Rockwell Medical made up 0.29% of Blue Clay Capital Management's portfolio in Q3 2016, its #68 holding.
  • 88 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2016.

Based on Blue Clay Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.